Omega Protein


Omega Protein Reports 3 Cents Per Share Second Quarter Profit

HOUSTON, July 29, 2005 - Omega Protein Corporation (NYSE symbol: OME), the nation's leading producer of Omega-3 fish oil and specialty fish meal products, today reported net income of $659,000 (3 cents a share) for the second quarter of 2005, compared with net income of $1.8 million (7 cents a share) for the second quarter of the previous year.

Revenues for the second quarter ended June 30, 2005 were $27.5 million compared with revenues of $26.5 million for the comparable quarter of 2004. Omega Protein recorded operating income of $0.8 million for the 2005 second quarter, versus operating income of $3.0 million for the second quarter of 2004.

For the six months ended June 30, 2005, the Company had revenues of $51.3 million, compared with $51.5 million in revenues for the first six months of 2004. Omega Protein recorded operating income of $1.0 million for the six-month period in 2005, versus operating income of $4.2 million for the comparable period a year earlier. The Company had net income of $766,000 (3 cents a share) for the 2005 six-month period, compared with net income of $2.5 million (10 cents a share) for the first six months of 2004.

Omega Protein's second quarter results, as well as the results for the first six months of 2005, reflect reduced margins primarily due to higher cost of inventories carried forward from the 2004 fiscal year, partially offset by higher prices received during the current year.


Omega Protein Corporation is the nation's largest manufacturer of heart-healthy fish oils containing Omega-3 fatty acids for human consumption, as well as specialty fish meals and fish oil used as value-added ingredients in aquaculture, swine and other livestock feeds. Omega Protein makes its products from menhaden, an Omega-3 rich fish that is not utilized as seafood, but which is abundantly available along the U.S. Gulf of Mexico and Atlantic Coasts.


Special Note Regarding Forward-Looking Statements: The statements contained in this press release that are not historical facts are forward-looking statements that involve a number of risks and uncertainties. The actual results of future events described in any of these forward-looking statements could differ materially from those stated in the forward-looking statements. Important factors that could cause actual results to be materially different from those forward -looking statements include, among others, (1) the Company's ability to meet its raw material requirements through its annual menhaden harvest, which is subject to fluctuations due to natural conditions over which the Company has no control, such as varying fish population, adverse weather conditions and disease; (2) the impact of worldwide supply and demand relationships on prices for the Company's products; and (3) fluctuations in the Company's quarterly operating results due to the seasonality of the Company's business and its deferral of inventory sales based on worldwide prices for competing products. These and other factors are described in further detail in Omega's filings with the Securities and Exchange Commission, including its 2002 Annual Report on Form 10K under the headings, Management's Discussion and Analysis of Financial Condition and Results of Operations Significant Factors That May Affect Forward-Looking Statements and Seasonality and Quarterly Results.

Contact: Investor Relations Department (713) 623-0060 or news@omegahouston.com


OMEGA PROTEIN CORPORATION
Statement of Operations
(Unaudited)
 
  Three Months
Ended June 30,
Six Months
Ended June 30,
  2005 2004 2005 2004
  (in thousands, except per share amounts)
Revenues $27,510 $26,456 $51,341 $51,512
Cost of sales 23,693 21,063 44,468 42,445
Gross profit 3,817 5,393 6,873 9,067
Selling, general, and
administrative expense
2,957 2,418 5,735 4,880
Loss on disposal of assets 96 4 96 4
Operating income 764 2,971 1,042 4,183
Interest expense, net (52) (183) (175) (370)
Other income (expense), net 230 (47) 191 (103)
Income before income taxes 942 2,741 1,058 3,710
Provision for income taxes 283 914 292 1,237
Net income $659 $1,827 $766 $2,473
Basic earnings per share $0.03 $0.07 $0.03 $0.10
Weighted average common shares outstanding 24,968 24,431 24,937 24,418
Diluted earnings per share $0.03 $0.07 $0.03 $0.09
Average common shares and
common share equivalents outstanding
26,307 26,507 26,383 26,425



OMEGA PROTEIN CORPORATION
CONDENSED BALANCE SHEET
(Unaudited)

  June 30, 2005 December  31, 2004
  (in thousands)
ASSETS    
Current assets $87,,941 $88,884
Property and equipment, net 102,668 97,776
Deferred tax assets, net 1,715 1,754
Other assets 1,967 1,798
   Total Assets $194,291 $190,162
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current liabilities $19,062 $15,707
Long-term debt, less current maturities 15,079 15,943
Other long-term liabilities 9,253 8,845
Stockhoders' equity 150,897 149,667
   Total liabilities and stockholders' equity $194,291 $190,162
   Book value per share outstanding $6.04 $6.02



  Omega Protein Corporation, Inc. All rights reserved.